Cetera Investment Advisers’s CorMedix CRMD Stock Holding History

Cetera Investment Advisers’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$128K	Sell	16,261 -14,253	-47%	-$113K	﹤0.01%	4617
2026 Q1	$207K	Sell	30,514 -25,816	-46%	-$191K	﹤0.01%	4265
2025 Q4	$655K	Buy	56,330 +17,526	+45%	+$194K	﹤0.01%	3200
2025 Q3	$451K	Buy	38,804 +25,950	+202%	+$314K	﹤0.01%	3456
2025 Q2	$158K	Sell	12,854 -118	-0.9%	-$1.3K	﹤0.01%	3784
2025 Q1	$79.9K	Buy	12,972 +288	+2%	+$2.98K	﹤0.01%	3812
2024 Q4	$103K	Sell	12,684 -6,940	-35%	-$69.3K	﹤0.01%	3572
2024 Q3	$159K	Buy	19,624 +4,722	+32%	+$25.6K	﹤0.01%	3451
2024 Q2	$64.5K	Buy	14,902 +2,750	+23%	+$14K	﹤0.01%	3571
2024 Q1	$51.5K	Buy	+12,152	New	+$42.1K	﹤0.01%	3563

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Cetera Investment Advisers's CRMD Position: Q2 2026 in Review

Cetera Investment Advisers reduced its CorMedix (CRMD) stake by 47% in Q2 2026, selling an estimated $113K and leaving 16,261 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #4617.

Cetera Investment Advisers first reported a position in CRMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $655K in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Cetera Investment Advisers held 16,261 shares of CorMedix worth $128K as of Q2 2026.
Cetera Investment Advisers sold 14,253 CorMedix shares in Q2 2026, an estimated $113K.
CorMedix made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4617 holding.
Cetera Investment Advisers first reported a position in CorMedix in Q1 2024 and has held it in 10 quarters since.
Cetera Investment Advisers's CorMedix position peaked at $655K in Q4 2025.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.